Versius customer reach increases as CMR Surgical closes 2023 with strongest quarter on record
CMR Surgical (“CMR” or “the Company”), the global surgical robotics business, today announces a strong close to 2023.
- CMR Surgical (“CMR” or “the Company”), the global surgical robotics business, today announces a strong close to 2023.
- The Versius Surgical Robotic System is being used to perform benign and complex surgical procedures around the world, including low anterior resections, prostatectomies, lobectomies and hysterectomies.
- Additionally, the launch of new advanced technologies for Versius – across both hardware and software – will be a gamechanger this year.
- If you wish to see more, please contact CMR Surgical at: